neurobrucellosis

A triple therapy of doxycycline, with rifampin and cotrimoxazole, has been used successfully to treat neurobrucellosis.

In 1989, neurologists in Saudi Arabia discovered neurobrucellosis, a neurological involvement in brucellosis.

Later complications may include arthritis or epididymoorchitis, spondylitis, neurobrucellosis, liver abscess formation, and endocarditis, the latter potentially fatal.

The disease's sequelae are highly variable and may include granulomatous hepatitis, arthritis, spondylitis, anaemia, leukopenia, thrombocytopenia, meningitis, uveitis, optic neuritis, endocarditis, and various neurological disorders collectively known as neurobrucellosis.